FDG PET studies in the differential diagnose of atypical parkinsonism and dementia syndromes.
Objective: To describe the fluorodeoxyglucose (FDG) metabolic pattern and clinical features in patients with clinical diagnose of atypical parkinsonism such as Progressive Supranuclear Palsy (PSP),…Semi-automated MRI algorithm using susceptibility weighted imaging for differentiating multiple system atrophy with parkinsonism from Parkinson Disease
Objective: To investigate the diagnostic value of semi-automated diagnostic algorithm using 3T-MR susceptibility-weighted image (SWI) for multiple system atrophy with parkinsonism (MSA-p). Background: Iron deposition…MRI-based Brain Networks of Perfusion and Structural Abnormalities in Patients with Cerebellar Variant of Multiple System Atrophy
Objective: To identify MRI-based brain networks of cerebral perfusion and structural abnormalities in cerebellar variant of MSA. Background: MSA consists clinically of parkinsonian (MSA-P) and cerebellar (MSA-C) variants. Previous FDG PET studies have…Specific Metabolic Brain Networks Associated with Parkinsonian and Cerebellar Variants of Multiple System Atrophy
Objective: To identify specific metabolic brain networks for parkinsonian (MSA-P) and cerebellar (MSA-C) variants of MSA. Background: MSA is associated with a disease-related metabolic brain network (MSARP)…Structural brain changes in patients with Multi System Atrophy: A VBM and DTI based study.
Objective: To evaluate the grey matter (GM) and white matter (WM) changes in patients with Multiple System Atrophy (MSA) using MRI. Background: MSA is a…Improved diagnosis of dementia with Lewy bodies by the combination of Tc-99m ECD SPECT with eZIS analysis and quantitative TRODAT-1 SPECT images
Objective: The development of easily useful neuroimaging may resolve to the delays of diagnosis. Background: Dementia with Lewy bodies (DLB) is easy to be misdiagnosed…Putaminal Diffusion Imaging for the Differential Diagnosis of the Parkinsonian Variant of Multiple System Atrophy from Parkinson’s Disease: Impact of Segmentation Accuracy
Objective: To evaluate different approaches of segmentation of the putamen in order to discriminate PD from MSA-P based on putaminal diffusion imaging. Background: Differences in prognosis…In vivo evaluation of tau and amyloid pathology in Corticobasal Syndrome
Objective: To assess in vivo, with molecular imaging the brain distribution of tau aggregates ([18F]AV1451 PET) and β-amyloid depositions ([18F]AV45 PET) in patients with Corticobasal…PBB3 Imaging in Parkinsonian disorders: evidence for binding to abnormally aggregated proteins in addition to tau proteins
Objective: To study selective regional binding for tau pathology in vivo, using PET with [11C]PBB3 ([11C]methylamino pyridin-3-yl buta-1,3-dienyl benzo[d]thiazol-6-ol) in tauopathies, and in conditions not…Pattern of MRI findings in ephedronic encephalopathy
Objective: Objective of the study was to summarize the typical neuroradiological picture of ephedronic encephalopathy and its clinical correlates. Background: Methcathinone (Ephedrone, Jeff etc.) emerged as…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.